-
1
المؤلفون: Yung-Chi Cheng
المصدر: Chinese Journal of Integrative Medicine
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, 2019-20 coronavirus outbreak, China, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pneumonia, Viral, MEDLINE, Severe Acute Respiratory Syndrome, Risk Assessment, Severity of Illness Index, Drug Administration Schedule, Lopinavir, Administration, Inhalation, medicine, Humans, Pharmacology (medical), Intensive care medicine, Pandemics, Integrative Medicine, Dose-Response Relationship, Drug, business.industry, COVID-19, Interferon-alpha, General Medicine, Middle Aged, Survival Rate, Complementary and alternative medicine, Medicine public health, Commentary, Female, Integrative medicine, business, Coronavirus Infections, Drugs, Chinese Herbal, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f5a9a65aeb1a892bde3ab3ed12357d6
http://europepmc.org/articles/PMC7533667